
    
      The objectives of this study are to obtain survival and outcomes data on the Alloclassic速
      Variall速 Cup in combination with the BIOLOX速 delta Taper Liner and a BIOLOX速 delta Femoral
      Head used in primary total hip arthroplasty. This will be done by analysis of standard
      scoring systems, radiographs and adverse event records.

      Two sites are involved in this study, enrolling a total of 100 patients for the study. All
      subjects were required to participate in the Informed Consent Process.
    
  